Medical Display Monitor Market Analysis, Demand, and Growth Opportunities

The market is mainly driven by increasing prevalence of chronic diseases, increasing demand for minimally invasive treatments, rising adoption of hybrid operating room (OR) technologies, and short replacement cycle of medical display technologies.

Among all technologies, the demand for organic light-emitting diode (OLED) technology is expected to exhibit the fastest growth in the medical display monitor market, with a CAGR of 5.4%, during the forecast period. The technology is also predicted to generate revenue of more than $70.0 million by 2023.

Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/medical-display-monitor-market



Displays with 5MP–8MP resolution held the largest share in the medical display monitor market in 2017, accounting for 30.5% share. This can be attributed to the fact that these monitors offer better-quality images in various surgical and diagnostic applications, as compared to other monitors. During the forecast period, the market for colored medical display monitors is expected to witness faster growth, at a CAGR of 5.2%. This is because of the high preference for these monitors for surgical and diagnostic purposes.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/medical-display-monitor-market/report-sample

Monitors of 23.0–26.9-inch panel sizes held the largest share in the medical display monitor market in 2017, accounting for 38.7% share. Diagnostics forms the largest application area of medical display monitors and is also anticipated to project the fastest growth, at a CAGR of 5.3%, in the market, during the forecast period. This can be attributed to the increasing adoption of these monitors in various imaging techniques, such as X-ray, magnetic resonance imaging, and computed tomography.
During the forecast period, the medical display monitor market is expected to witness the fastest growth in LATAM. Advanced diagnostic imaging technologies are leading to a high demand for medical imaging devices, which, in turn, is boosting the market growth in LATAM.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=medical-display-monitor-market

According to a report published by the United Nations Department of Economic and Social Affairs (UNDESA) in 2017, the number of people aged 65 years and above in Brazil is expected to reach approximately 58 million by 2050. Therefore, increasing requirement for medical imaging devices and rising geriatric population in LATAM are expected to drive the medical display monitor market growth in the region in the coming years.

Some of the other key players operating in the global medical display monitor market are Siemens AG, Sony Corporation, Novanta Inc., Barco NV, LG Display Co. Ltd., Advantech Co. Ltd., Jusha Medical, JVCKENWOOD Corporation, and Steris plc.

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Breast Biopsy Devices Market Detailed Strategies, Financials, and Recent Developments

Global breast biopsy devices market is forecasted to generate a revenue of $1.4 billion by 2023, P&S Market Research
The growth is mainly led by product and technological innovations, increasing incidence of breast cancer cases, rising propensity for minimally invasive surgeries, and mounting number of breast cancer screening programs.

On the basis of the procedure conducted for breast biopsy, the market is categorized into vacuum-assisted, core needle, fine needle aspiration, and surgical biopsy. Vacuum-assisted biopsies have been accounting for the largest share in the breast biopsy devices market till now. It is also expected to be the fastest growing category during the forecast period. This can be mainly attributed to its various advantages, such as its ability to precisely locate the area of abnormality using imaging guidance, so that samples are removed only from the region of interest.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/breast-biopsy-devices-market/report-sample

According to International Agency for Research on Cancer, in 2012, breast cancer incidences reported in India were 144,937 and the mortality rate in women in India was 70,218, which is comparatively higher than China (47,989). In order to balance these statistics, the government and several other organizations are also creating awareness about breast cancer. For instance, October has been designated as the breast cancer awareness month by the government of India, which is an annual campaign to educate people about breast cancer. Also, the Pink Initiative, a registered charity in Mumbai, creates awareness about breast cancer amongst women in India. These factors cumulatively lead to growth in the demand of breast biopsy devices in the region.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=breast-biopsy-devices-market

Globally, key players in the breast biopsy devices industry are launching products to gain a larger market share. For instance, in November 2017, Siemens Healthineers, a subsidiary of Siemens AG, unveiled its new Mammomat Revelation imaging system at the 2017 Radiological Society of North America (RSNA) Annual Meeting in Chicago. 3D HD Breast Biopsy uses company’s 50-degree wide-angle HD breast tomosynthesis to obtain more targeted, accurate biopsies at a lower dose. The system also offers titanium contrast-enhanced mammography exams and automated breast density measurement.

Some of the other major players operating in the breast biopsy devices market include Danaher Corporation, Argon Medical Devices Inc., Becton, Dickinson and Company, Sterylab S.R.L., Scion Medical Technologies LLC, Planmed Oy, Medtronic plc, and Cook Medical LLC.

Contact:
P&S Intelligence
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Medical Aesthetics Market Comprehensive Review of its Applications, Demand, and Growth Opportunities

The medical aesthetics market is expected to reach $19.4 billion by 2023, growing at a CAGR of 12.2% between 2017-2023.
Advancement in laser technology, growing awareness among consumers, and health benefits of medical aesthetics procedures have been driving the market. The market is further expected to gain revenue due to shift in the preference from surgical to non-surgical procedures. There has been a significant growth in non-surgical medical spa procedures in the recent years, resulting from better technologies, such as intense pulsed light and advanced laser-based aesthetics equipment.

In terms of product, the medical aesthetics market is classified into injectables, topicals, energy-based aesthetics, breast implants and others. The other medical aesthetics products primarily include microdermabrasion devices, liposuction tools, tissue matrices, microneedles, fat transfer systems, and jet propulsion systems. Among different medical aesthetics products, injectables held the largest share in the market in 2016, primarily due to high sales of botulinum toxin. Injectables, which includes neurotoxin and dermal fillers, accounted 35.3% of the global medical aesthetic products sales. Topicals, the second largest medical aesthetics product segment, witnessed the highest growth during historical period. The highest growth of topicals is attributed to their ability to treat several skin conditions without any usage of uncomfortable procedures. However, during the forecast period, the global energy-based aesthetics market is expected to grow at the fastest rate due to the increasing adoption of laser and radio frequency devices in aesthetics.


Download Report Sample at: https://www.psmarketresearch.com/market-analysis/medical-aesthetics-market/report-sample


The Asia-Pacific medical aesthetics market size is set to cross $5.0 billion by 2023, growing at a CAGR of 16.3% between 2017-2023. The Asia-pacific countries are experiencing a significant increase in the use of cosmetic treatments driven by factors such as expanding middle class population with increasing disposable income, increasing awareness about skin treatments and aging population, decrease in social stigma and taboo attached with these treatments and rise in number of tourists in these regions opting for cosmetic procedures. Countries such as China are easily open for the players for further expansion due to lesser stringent regulations. Some of the most popular treatments in the region are skin brightening, skin resurfacing and hair removal procedures, with procedures such as body shaping and skin tightening gaining further popularity.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=medical-aesthetics-market

Some of the key players operating in the medical aesthetics market include Allergan plc., Valeant Pharmaceuticals International, Inc., Johnson & Johnson, Cutera Inc., Alma Lasers Ltd, Merz GmbH & Co. KGaA, Hologic Inc., Fonon Corporation, Nestle Skin Health S.A., Lumenis ltd.


Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Hypodermic Needle Market Analysis by Demand , Trends and Growth Opportunities

The global hypodermic needles market is expected to grow at a CAGR of 7.4% during 2016 - 2022.
The growth of the global market is largely driven by the high demand for vaccines and increasing compliance of safety needles. High prevalence of needle stick injuries during drug administration is a key concern for healthcare providers across the globe. Improper disposal of syringe and needles is creating the demand for advanced safety mechanisms in hypodermic needles. Globally, approximately 16 billion injections are administered every year as per the World Health Organization (WHO); however, all the syringes and needles are not properly disposed of. Therefore, several benefits of safety needles such as ease of use during injection and safe delivery of drug or medication are increasing their popularity among healthcare providers.

North America led the global hypodermic needle market in terms of size in 2015, owing to the increasing awareness of safe injectable technology, and increasing prevalence of chronic and lifestyle associated diseases. The U.S. contributed largest revenue to the North American as well as the global hypodermic needle market. The country is expected to remain the largest market for hypodermic needle globally during the forecast period.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/hypodermic-needles-market/report-sample



The information and data in the publication “Global Hypodermic Needle Market Size, Share, Development, Growth and Demand Forecast to 2022”, represents the research and analysis of data from various primary and secondary sources. An amalgamation of bottom-up and top-down has been used to calculate the market size. P&S Market Research analysts and consultants interacted with leading companies of the concerned domain to substantiate every value of data presented in the report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online and offline research.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hypodermic-needles-market

Among the different end users, hospitals were the largest user of hypodermic needles in 2015. High prevalence of chronic diseases, improving regulations for safety hypodermic needles, increasing government initiatives and geriatric population are the key drivers for the global hypodermic needle market in hospitals.
Some of the players operating in the global market include Vygon S.A., Catalent, Inc., Terumo Corporation, Retractable Technologies, Inc., Connecticut Hypodermics, Inc., MedPro Safety Products Inc., B. Braun Melsungen AG, Albert David Ltd., Becton, Dickinson and Company, and Medtronic plc.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Human Insulin Market Review of its Applications Growth Opportunities and Future Prospects

The global human insulin market is being driven by increasing prevalence of diabetic population, and rise in aging population. Diabetes is a chronic and non-communicable disease, and its global prevalence is increasing enormously. Rising prevalence of obesity, rising awareness about diabetic care, and technological advancement in insulin delivery devices are some of the factors driving the growth of the global human insulin market. Growing demand of biosimilar drugs, due to its cost effectiveness, pose an opportunity for the growth of the human insulin market. In addition, increasing usage of insulin pens for the administration of insulin helps to inject the accurate dose of insulin at a time. However, high insulin analog cost and strict regulatory requirements for approval of human insulin are inhibiting the growth of the global human insulin market.

On the basis of type of human insulin, the modern human insulin commands the larger share in the global market. The modern human insulin is also expected to grow at a CAGR (of 13%) than traditional human insulin during 2015 to 2020. The modern human insulin can be further categorized as long acting human insulin, rapid acting human insulin and premixed human insulin; wherein, the long acting human insulin commands the largest share in modern human insulin market but the premixed human insulin exhibited the highest growth rate. The long acting human insulin is prescribed by physicians for the treatment of type 2 diabetes. It is absorbed slowly and works for long time to control the sugar level between meal and sleep. It is administered once or twice a day and the onset time for long acting human insulin is 1 hour, and has its effect for 20 hours to 26 hours.

Download Sample of This Research Report: https://www.psmarketresearch.com/market-analysis/human-insulin-market/report-sample

Increasing prevalence of diabetes, increasing number of geriatric population, rising prevalence of obesity and increasing R&D investment for more effective insulin are driving the growth of the human insulin market in North America. The North American human insulin market is expected to grow by a CAGR of 11.8% during the period 2015 to 2020. In Europe, according to International Diabetic Federation in 2013, approximately 52 million people were suffering from diabetes in Europe. The European human insulin market is expected to grow by a CAGR of 12.6% during the period 2015 to 2020. Thus, increasing prevalence of diabetes would increase the usage of human insulin.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=human-insulin-market


Also, in Asia-Pacific, several government initiatives are implemented to create awareness about prevention and treatment of diabetes. The government is also taking initiatives to improve healthcare infrastructure and provide treatment in rural areas. In Asia-Pacific, the human insulin market is expected to witness CAGR of 13.9% during the period 2015 to 2020, to achieve $12,074.3 million value by 2020.
The global human insulin market has a fragmented structure with large number of companies operating in the market. The key players in the human insulin market include Sanofi, Novo Nordisk A/S, Eli Lilly and Company, GlaxoSmithKline Plc, Pfizer, Inc., Merck & Co., and Julphar.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com